Correlation Between Citigroup and Nu Med
Can any of the company-specific risk be diversified away by investing in both Citigroup and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Nu Med Plus, you can compare the effects of market volatilities on Citigroup and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Nu Med.
Diversification Opportunities for Citigroup and Nu Med
Pay attention - limited upside
The 3 months correlation between Citigroup and NUMD is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Citigroup i.e., Citigroup and Nu Med go up and down completely randomly.
Pair Corralation between Citigroup and Nu Med
Taking into account the 90-day investment horizon Citigroup is expected to generate 9.89 times less return on investment than Nu Med. But when comparing it to its historical volatility, Citigroup is 9.21 times less risky than Nu Med. It trades about 0.06 of its potential returns per unit of risk. Nu Med Plus is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1.60 in Nu Med Plus on October 5, 2024 and sell it today you would lose (0.06) from holding Nu Med Plus or give up 3.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 99.8% |
Values | Daily Returns |
Citigroup vs. Nu Med Plus
Performance |
Timeline |
Citigroup |
Nu Med Plus |
Citigroup and Nu Med Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and Nu Med
The main advantage of trading using opposite Citigroup and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Money Managers Screen money managers from public funds and ETFs managed around the world |